Company profile

AN2 Therapeutics, Inc. insider acquisitions

Company CIK 0001880438 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
ANTX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Marks Gilbert LynnMarks Gilbert LynnMartin Patricia A.Martin Patricia A.Aziz KabeerAziz KabeerMarks Gilbert Lynn · October 12, 2026 · Stock award · Common StockMartin Patricia A. · October 12, 2026 · Stock award · Common StockAziz Kabeer · October 12, 2026 · Stock award · Common StockMarks Gilbert Lynn · October 10, 2025 · Stock award · Common StockAziz Kabeer · October 10, 2025 · Stock award · Common StockMartin Patricia A. · October 10, 2025 · Stock award · Common StockOct 10, 2025Oct 12, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 12, 2026AN2 Therapeutics, Inc.Common StockMarks Gilbert LynnStock award
Oct 12, 2026AN2 Therapeutics, Inc.Common StockMartin Patricia A.Stock award
Oct 12, 2026AN2 Therapeutics, Inc.Common StockAziz KabeerStock award
Oct 10, 2025AN2 Therapeutics, Inc.Common StockMarks Gilbert LynnStock award
Oct 10, 2025AN2 Therapeutics, Inc.Common StockAziz KabeerStock award
Oct 10, 2025AN2 Therapeutics, Inc.Common StockMartin Patricia A.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

ANTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardCommon StockNon-derivative security · Code A2,2830Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A3890Value: 0Currency not specifiedView ↗
Trade:
Aziz KabeerDirector
Stock awardCommon StockNon-derivative security · Code A2,4650Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A10,3670Value: 0Currency not specifiedView ↗
Trade:
Aziz KabeerDirector
Stock awardCommon StockNon-derivative security · Code A10,3670Value: 0Currency not specifiedView ↗
Trade: Stock awardCommon StockNon-derivative security · Code A3,2740Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →